Volume 6 Supplement 1
Whole-genome association studies of alcoholism with loci linked to schizophrenia susceptibility
© Namkung et al; licensee BioMed Central Ltd 2005
Published: 30 December 2005
Alcoholism is a complex disease. There have been many reports on significant comorbidity between alcoholism and schizophrenia. For the genetic study of complex diseases, association analysis has been recommended because of its higher power than that of the linkage analysis for detecting genes with modest effects on disease.
To identify alcoholism susceptibility loci, we performed genome-wide single-nucleotide polymorphisms (SNP) association tests, which yielded 489 significant SNPs at the 1% significance level. The association tests showed that tsc0593964 (P-value 0.000013) on chromosome 7 was most significantly associated with alcoholism. From 489 SNPs, 74 genes were identified. Among these genes, GABRA1 is a member of the same gene family with GABRA2 that was recently reported as alcoholism susceptibility gene.
By comparing 74 genes to the published results of various linkage studies of schizophrenia, we identified 13 alcoholism associated genes that were located in the regions reported to be linked to schizophrenia. These 13 identified genes can be important candidate genes to study the genetic mechanism of co-occurrence of both diseases.
Alcoholism is a complex disease that tends to run in families. It has been reported that alcoholism is accompanied by many other psychiatric disorders, including schizophrenia . The co-occurrence of these psychiatric disorders and alcoholism can be explained in several ways. First, patients may use alcohol to relieve the symptom of mental diseases. Second, disruption of neurochemical systems may cause psychiatric disorders and alcoholism simultaneously. Several molecules including serotonin, neuropeptide Y, and dopamine have been studied to explore this hypothesis. Third, the genes responsible for these diseases may transmit together because they are closely linked on a chromosome and co-segregate without any functional relationship.
Linkage or association study of polymorphisms may provide useful information on the genetic mechanism of co-occurrence of psychiatric disorders and alcoholism. Among psychiatric disorders, schizophrenia is also known to be affected by multiple genes . Schizophrenia patients with substance abuse problems, especially alcoholics, are clinically important because they usually have a poor prognosis [3, 4].
In this study, we are interested in determining whether there is any common genetic factor that may increase the susceptibility of alcoholism and schizophrenia simultaneously. Although linkage analysis has been a successful choice for genetic analysis of Mendelian diseases, association analysis has shown to have greater power than linkage analysis when used to detect genes with modest effect on disease . Thus, we conduct genome-wide association tests to find alcoholism susceptibility loci by analyzing the Collaborative Study on the Genetics of Alcoholism (COGA) data from the Genetic Analysis Workshop 14 (GAW 14). Because COGA data were collected from multiplex families, we consider only the approaches that take advantage of the whole pedigree data.
In our analysis, we primarily use the pedigree disequilibrium test (PDT) . The PDT is an extension of the transmission disequilibrium test (TDT) , and it has been widely applied to the analysis of large pedigree data including multiple nuclear family or sibling pairs. We test association for both alleles and genotypes using the PDT. Additionally, we apply the generalized estimating equations (GEE) approach  to test the association for each genotype with the disease while adjusting for some phenotypic covariates. By using both the PDT and GEE approaches we obtain candidate markers for alcoholism susceptibility and then compare them with the loci that are reported to be linked to schizophrenia.
Disease affection status was defined by using both ALDX1 (DSM-III-R+Feighner) and ALDX2 (DSM-IV). A sample with ALDX1 = 5 or ALDX2 = 5 was defined as the affected, and ALDX1 = 1 or ALDX2 = 1 as the unaffected. Others treated as non-informative data. With these criteria, 668 were classified as "affected" and 285 as "unaffected" from 1,614 individuals.
For the comparison of association with the linkage analysis, we first performed nonparametric linkage (NPL) analysis for microsatellites. Due to computational problems, NPL analysis for single-nucleotide polymorphisms (SNPs) was not performed. The linkage analysis for microsatellites was performed by using NPL procedure of SIMWALK2 software . To transform GAW14 data into input format for SIMWALK2 software, we used MEGA2 software .
To test for association of microsatellites and SNPs with disease, we used the PDT. Because the PDT is a family-based association test, it can avoid problems of false positives caused by population stratification. There are two types of the PDT available: allele-based PDT and genotype-based PDT (genotype-PDT). For the allele-based PDT, two test statistics are commonly used: sum-PDT and average-PDT. The sum-PDT gives more weight to families with a larger number of multiple affected individuals. In contrast, the average-PDT gives equal weight to all families . The genotype-PDT tests for association between genotypes and disease. This is more powerful than the allele-based PDT when the genetic effect of an allele is dominant or recessive rather than additive. The genotype-PDT can test multilocus effects without the ambiguities associated with haplotype analysis, and allow for testing interactions among markers . We used the genotype-PDT to test for association between disease and genotypes at a single locus as well as at multiple loci. All the tests were conducted by using PDT 5.1 software.
The GEE approach accounts for familial correlation in the analysis and allows for adjustment for covariates such as sex and age in selecting significant genotypes of SNPs. For the binary response of disease affection status, the model is given by
Logit [pr(D ij )] = β0 + βageage ij + βsexsex ij + βgenogenotype ij , where
D ij is the affection status of jth individual in ith family
(affected = 1, unaffected = 0)
We conducted this analysis using R software http://www.r-project.org/.
After identifying SNPs associated with alcoholism, we obtained gene information from the dbSNP website http://www.ncbi.nlm.nih.gov/SNP/. The additional information of genes such as chromosomal location and functional annotation was obtained from the SOURCE website http://source.stanford.edu/. Then, we compared the genes and regions in which they are located to published results of various linkage studies of schizophrenia.
Preliminary analysis using microsatellites
Before performing the association analysis using large number of SNPs, we conducted linkage and association analyses for microsatellite markers. At first, a chromosome-wide association test was performed using two PDT statistics: average-PDT and sum-PDT. At the 5% significance level (α = 0.05) for either the sum-PDT or average-PDT, this preliminary test shows that 6 microsatellites from chromosomes 6 and 8 tend to have associations with alcoholism. Among them, two microsatellites are located adjacent to the schizophrenia susceptibility region [2, 13]: 1) D6S474 (6q21) with p-values 0.0182 for the sum-PDT and 0.0144 for the average-PDT, 2) D8S1106 (8p21 SCZD6) with p-value 0.0155 for the sum-PDT.
To test for linkage of markers to alcoholism, we performed NPL analysis. Chromosome 7 showed two peaks of moderate linkage disequilibrium with alcoholism at D7S673 (30.1 cM) with -log p-value 2.077 (NPL-PAIR) and D7S820 (107.5 cM) with 2.041.
Association test for SNPs
From 15,878 autosomal SNPs, we first selected SNPs that have p-values smaller than 0.05 for both allele based PDTs. One hundred and ninety SNPs had p-values less than 0.01 and 18 SNPs had p-values less than 0.001 by either of the two PDTs. Using the genotype-PDT we identified 138 and 16 SNPs showing significant association at α = 0.01 and 0.001, respectively. Among 138 SNPs, 94 also showed significant associations for the allele-based PDT at α = 0.01.
As an alternative, we also applied the GEE approach, which considers familial correlation. From this analysis, only 65 SNPs showed p-values less than 0.01. rs1262129 appeared to be most significant (p-value = 0.000068). Among the 65 significant SNPs, two SNPs were also significant for the genotype-PDT: tsc0253130 (p-value = 0.0007) and tsc0834636 (p-value = 0.0054). The number of significant SNPs is much smaller than that of PDT. It is probably due to the lack of power caused by ignoring genetic inheritance information in the GEE approach.
In addition, we performed multipoint association analysis using the multipoint genotype-PDT. The multipoint genotype-PDT tests for association of multiple loci without haplotyping. We conducted 2-point, 3-point, and 5-point analysis for the adjacent markers. We obtained 98 SNP pairs from the 2-point analysis, and 42 SNP triple sets from the 3-point analysis at the 1% significance level. The 5-point analysis resulted in no significant marker sets. Some identified SNP sets did not contain any SNP that showed significant association from the single-locus test. This underscores the importance of interactions among multiple markers to search for candidate disease genes.
Using the dbSNP and the SOURCE database website, we selected intragenic SNPs among those associated with alcoholism. A total of 74 known genes were found to contain the significant SNPs after hypothetical genes or open reading frames were excluded. Two of these genes, GABRA1 (tsc0325674, p-value = 0.0035 by the average-PDT) and CHRNA3 (rs1878399, p-value = 0.0083 by the average-PDT) are neurotransmitter receptors; NTRK2 (tsc0656804, p-value = 0.0041 by the average-PDT) has function of neurogenesis. Of note, GABRA1 is a member of the same gene family as GABRA2, which was reported recently to be associated with alcoholism .
The SNPs showing significant association located in major schizophrenia susceptibility candidate regions
Reported schizophrenia regione
Summary and Discussion
Through the analysis using microsatellites, we obtained rough regions showing modest linkage or association with alcoholism. Later, we found that the most significant SNP, tsc0593964, was located near the modest linkage peak on chromosome 7.
We conducted the genome-wide association analysis for large number of SNPs by using different association methods such as the allele-based PDT, genotype-based PDT for single locus or for multiple loci, and GEE. Each method resulted in a different number of significant markers. Thus, the results should be interpreted carefully. We think it would be important to compare the results in a more systematic way by using simulation studies in the future.
With additional biological information such as gene names and functions, the list of selected candidate markers may be quite useful for the study of complex disease, even though the 1% significance level is not stringent enough for the genome-wide tests. We searched for gene information of the selected SNPs and found that some of the genes are related to the neurochemical system.
The evidence for significant co-morbidity of substance abuse, especially alcoholism, and schizophrenia is very robust . The genetic relationship between two diseases has not yet been explained. We think our findings of the 13 genes, which are associated with alcoholism and also located in schizophrenia linkage regions, can be helpful to study genetic factors responsible for both diseases.
Collaborative Study on the Genetics of Alcoholism
Genetic Analysis Workshop 14
Generalized estimating equation
Pedigree disequilibrium test
Transmission disequilibrium test
The authors thank for two anonymous reviewers for their helpful comments. This work was supported by the National Research Program of Korea Science and Engineering Foundation.
- Ross HE, Glaser FB, Germanson T: The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry. 1988, 45: 1023-1031.View ArticlePubMedGoogle Scholar
- Michael CO, Nigel MW, Michael JO: Recent advances in the genetics of schizophrenia. Hum Mol Genet. 2003, 12 (review issue 2): R125-R133.Google Scholar
- Crome IB: Alcoholism and schizophrenia: a challenge for treatment and research. Addiction. 2000, 95: 1859-1860. 10.1046/j.1360-0443.2000.9512185914.x.View ArticlePubMedGoogle Scholar
- Soyka M: Alcoholism and schizophrenia. Addiction. 2000, 95: 1613-1618. 10.1080/09652140020000849.View ArticlePubMedGoogle Scholar
- Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science. 1996, 273: 1516-1517. 10.1126/science.273.5281.1516.View ArticlePubMedGoogle Scholar
- Martin ER, Monks SA, Warren LL, Kaplan NL: A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet. 2000, 67: 146-154. 10.1086/302957.PubMed CentralView ArticlePubMedGoogle Scholar
- Spielman RS, Ralph EM, Warren JE: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993, 52: 506-516.PubMed CentralPubMedGoogle Scholar
- Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986, 42: 121-130. 10.2307/2531248.View ArticlePubMedGoogle Scholar
- Sobel E, Lange K: Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker sharing statistics. Am J Hum Genet. 1996, 58: 1323-1337.PubMed CentralPubMedGoogle Scholar
- Mukhopadhyay N, Almasy L, Schroeder M, Mulvihill WP, Weeks DE: Mega2, a data-handling program for facilitating genetic linkage and association analyses. Am J Hum Genet. 1999, 65: A436-Google Scholar
- Martin ER, Bass MP, Kaplan NL: Correction for a potential bias in the pedigree disequilibrium test. Am J Hum Genet. 2001, 68: 1065-1067. 10.1086/319525.PubMed CentralView ArticlePubMedGoogle Scholar
- Martin ER, Bass MP, Gilbert JR, Pericak-Vance MA, Hauser ER: Genotype-based association test for general pedigrees: the genotype-PDT. Genet Epidemiol. 2003, 25: 203-213. 10.1002/gepi.10258.View ArticlePubMedGoogle Scholar
- Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Housman DE, Kazazian HH, Antonarakis SE, Pulver AE: Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet. 1998, 20: 70-73. 10.1038/1734.View ArticlePubMedGoogle Scholar
- Edenberg HJ, Dick DM, Xuei X, Tian H, Almasy L, Bauer LO, Crowe RR, Goate A, Hesselbrock V, Jones K, Kwon J, Li TK, Nurnberger JI, O'Connor SJ, Reich T, Rice J, Schuckit MA, Porjesz B, Foroud T, Begleiter H: Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet. 2004, 74: 705-714. 10.1086/383283.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.